Showing 1–8 of 8 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
World Health Organization. Regional Office for South-East Asia
…lts of which shows that prevalence of Multi Drug Resistance Tuberculosis (MDR-TB) in new cases (1.4%) was lower than estimated, but the prevalence of MDR TB in previously treated cases (28.5%) was much higher. Though the rate is low compared with other countries, the high TB prev…
World Health Organization. Regional Office for South-East Asia
…nal laboratory settings. The Xpert MTB/RIF assay detects M. tuberculosis as well as rifampicin resistance-conferring mutations using three specific primers and five unique molecular probes to ensure a high degree of specificity. The assay provides results directly from sputum wit…
World Health Organization. Regional Office for South-East Asia
…ectively respond to multi-drug resistant and HIV-associated tuberculosis were discussed and country experiences shared. Member States also presented their plans for the coming year and the technical assistance and resource requirements to effectively carry out all planned interve…
World Health Organization. Regional Office for South-East Asia
…ogress towards the Millennium Development Goals relating to tuberculosis (TB). The estimated incidence of all forms of TB, estimated prevalence of all forms of TB and estimated TB mortality all continue to show a downward trend. The treatment success rate among new smear-positive…
World Health Organization. Regional Office for the Eastern Mediterranean
World Health Organization. Regional Office for South-East Asia
World Health Organization. Regional Office for South-East Asia
World Health Organization. Regional Office for South-East Asia
The report summarizes the proceedings of the Meeting of Partners for TB control in the South-East Asia Region held in Jakarta, Indonesia, 27 to 30 November 2006. A review of the situation and progress in TB control in the Region was conducted and presentations made on experiences…